Duloxetine, a drug
approved in Canada, the US and Europe to treat major depression, is
approved in Europe to treat stress urinary incontinence — involuntary leakage of urine during exertion, sneezing or coughing — that affects an estimated 1 in 10 women.
Three drugs —
duloxetine, pregabalin and milnacipran — have been FDA -
approved to treat the disorder, but that's not your only recourse.
Next Page: Cymbalta [pagebreak] Cymbalta How it works:
Approved in 2008 for use in fibromyalgia (and previously approved for diabetic retinopathy and depression), Cymbalta (duloxetine) is a serotonin and norepinephrine reuptake inhibitor (SNRI)-- a type of antidepressant that raises the levels of the neurotransmitters serotonin and norepinephrine in the brain a
Approved in 2008 for use in fibromyalgia (and previously
approved for diabetic retinopathy and depression), Cymbalta (duloxetine) is a serotonin and norepinephrine reuptake inhibitor (SNRI)-- a type of antidepressant that raises the levels of the neurotransmitters serotonin and norepinephrine in the brain a
approved for diabetic retinopathy and depression), Cymbalta (
duloxetine) is a serotonin and norepinephrine reuptake inhibitor (SNRI)-- a type of antidepressant that raises the levels of the neurotransmitters serotonin and norepinephrine in the brain and body.